Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2004-07-07 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINTE-MARIE-SUR-OUCHE (21410), Cote-d'Or
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA VALLEE DE L'OUCHE : revenue, balance sheet and financial ratios
PHARMACIE DE LA VALLEE DE L'OUCHE is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINTE-MARIE-SUR-OUCHE (21410),
this company of category PME
shows in 2022 a revenue of 1.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA VALLEE DE L'OUCHE (SIREN 477731285)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
1 115 935 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
39 534 €
28 503 €
19 727 €
36 560 €
68 751 €
38 560 €
42 364 €
51 763 €
45 174 €
55 149 €
EBITDA
N/C
N/C
N/C
35 573 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
3.3%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE LA VALLEE DE L'OUCHE generates positive net income of 40 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 55 k€ -> 40 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
39 534 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 22%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 74%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
22.021%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
74.36%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA VALLEE DE L'OUCHE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
92.584
73.421
63.216
55.704
47.691
42.465
37.734
24.83
23.545
22.021
Financial autonomy
47.148
51.85
54.731
56.646
61.409
63.251
66.571
71.899
69.927
74.36
Repayment capacity
None
None
None
None
None
None
11.117
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
2.608%
None%
None%
None%
Sector positioning
Debt ratio
22.022025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good
In 2025, the debt ratio of PHARMACIE DE LA VALLEE DE... (22.02) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
74.36%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent
In 2025, the financial autonomy of PHARMACIE DE LA VALLEE DE... (74.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 164.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
164.501
Liquidity indicators evolution PHARMACIE DE LA VALLEE DE L'OUCHE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
77.061
65.998
100.853
116.836
124.366
161.298
189.779
114.136
124.376
164.501
Interest coverage
None
None
None
None
None
None
0.306
None
None
None
Sector positioning
Liquidity ratio
164.52025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average+20 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE LA VALLEE DE... (164.50) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA VALLEE DE L'OUCHE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
53 197 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
14
0
0
0
Customer payment term (days)
132
0
0
0
0
0
6
0
0
0
Supplier payment term (days)
968
0
0
0
0
0
32
0
0
0
Positioning of PHARMACIE DE LA VALLEE DE L'OUCHE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE LA VALLEE DE L'OUCHE is estimated at
628 002 €
(range 426 165€ - 985 422€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
426k€628k€985k€
628 002 €Range: 426 165€ - 985 422€
NAF 5 année 2025
Valuation method used
Net Income Multiple
39 534 €
×
15.9x
=628 002 €
Range: 426 165€ - 985 422€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA VALLEE DE L'OUCHE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA VALLEE DE L'OUCHE
What is the revenue of PHARMACIE DE LA VALLEE DE L'OUCHE ?
The revenue of PHARMACIE DE LA VALLEE DE L'OUCHE in 2022 is 1.1 M€.
Is PHARMACIE DE LA VALLEE DE L'OUCHE profitable?
Yes, PHARMACIE DE LA VALLEE DE L'OUCHE generated a net profit of 40 k€ in 2025.
Where is the headquarters of PHARMACIE DE LA VALLEE DE L'OUCHE ?
The headquarters of PHARMACIE DE LA VALLEE DE L'OUCHE is located in SAINTE-MARIE-SUR-OUCHE (21410), in the department Cote-d'Or.
Where to find the tax return of PHARMACIE DE LA VALLEE DE L'OUCHE ?
The tax return of PHARMACIE DE LA VALLEE DE L'OUCHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA VALLEE DE L'OUCHE operate?
PHARMACIE DE LA VALLEE DE L'OUCHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart